Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 1
2002 2
2003 1
2006 2
2009 1
2010 2
2011 3
2012 3
2013 4
2014 5
2015 5
2016 8
2017 8
2018 5
2019 3
2020 3
2021 8
2022 10
2023 7
2024 2
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, Kern WV, Kim HB, Kim ES, Liao CH, Tilley R, Lopez-Cortés LE, Llewelyn MJ, Fowler VG, Thwaites G, Cisneros JM, Scarborough M, Nsutebu E, Gurgui Ferrer M, Pérez JL, Barlow G, Hopkins S, Ternavasio-de la Vega HG, Török ME, Wilson P, Kaasch AJ, Soriano A; International Staphylococcus aureus collaboration study group and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis. Kuehl R, et al. Lancet Infect Dis. 2020 Dec;20(12):1409-1417. doi: 10.1016/S1473-3099(20)30447-3. Epub 2020 Aug 4. Lancet Infect Dis. 2020. PMID: 32763194
[Afatinib (BIBW 2992)].
Prim N, Fore M, Mennecier B. Prim N, et al. Rev Pneumol Clin. 2014 Oct;70(5):279-85. doi: 10.1016/j.pneumo.2014.03.002. Epub 2014 May 27. Rev Pneumol Clin. 2014. PMID: 24878189 Review. French.
Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy.
Montero MM, Domene-Ochoa S, Prim N, Ferola E, López-Causapé C, Gomis-Font M, Ampuero-Morisaki MF, Echeverria D, Sorlí L, Luque S, Padilla E, Grau S, Oliver A, Horcajada JP. Montero MM, et al. Among authors: prim n. Eur J Clin Microbiol Infect Dis. 2025 May;44(5):1077-1087. doi: 10.1007/s10096-025-05061-4. Epub 2025 Feb 18. Eur J Clin Microbiol Infect Dis. 2025. PMID: 39964628 Free PMC article.
Synergistic efficacy of ceftazidime/avibactam and aztreonam against carbapenemase-producing Pseudomonas aeruginosa: insights from the hollow-fiber infection model.
Montero MM, Domene-Ochoa S, Prim N, Ferola E, López-Causapé C, Echeverria D, Morisaki MFA, Vega-Toribio V, Sorlí L, Luque S, Padilla E, Oliver A, Horcajada JP. Montero MM, et al. Among authors: prim n. Infect Dis (Lond). 2025 Jan;57(1):81-88. doi: 10.1080/23744235.2024.2396882. Epub 2024 Aug 30. Infect Dis (Lond). 2025. PMID: 39212630 Free article.
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review.
Echeverria-Esnal D, Sorli L, Navarrete-Rouco ME, Prim N, Barcelo-Vidal J, Conde-Estévez D, Montero MM, Martin-Ontiyuelo C, Horcajada JP, Grau S. Echeverria-Esnal D, et al. Among authors: prim n. Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):759-775. doi: 10.1080/14787210.2023.2223977. Epub 2023 Jun 14. Expert Rev Anti Infect Ther. 2023. PMID: 37294450 Review.
New Predictive Equation for the Estimation of Plasma Concentrations of Formed Colistin in Patients Treated With Colistimethate Sodium for Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S, Sorlí L, Li J, Fernández-Sala X, Berenguer N, Colominas-González E, Benítez-Cano A, Montero MM, Subirana I, Prim N, García-Paricio R, Horcajada JP, Grau S. Luque S, et al. Among authors: prim n. Ther Drug Monit. 2024 Oct 1;46(5):594-602. doi: 10.1097/FTD.0000000000001216. Epub 2024 Jul 9. Ther Drug Monit. 2024. PMID: 38984536
Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study.
Cercenado E, Alcalá L, Irigoyen-von-Sierakowski Á, Rodríguez-Sánchez B, Marín M; GEIRAS-SEIMC Study Group. Cercenado E, et al. Int J Antimicrob Agents. 2025 Sep;66(3):107534. doi: 10.1016/j.ijantimicag.2025.107534. Epub 2025 May 8. Int J Antimicrob Agents. 2025. PMID: 40345344 Free article.
Direct fluorescence-based lipase activity assay.
Diaz P, Prim N, Javier Pastor FI. Diaz P, et al. Among authors: prim n. Biotechniques. 1999 Oct;27(4):696-8, 700. doi: 10.2144/99274bm14. Biotechniques. 1999. PMID: 10524309 Free article. No abstract available.
Pharmacodynamic interaction of apotransferrin and anti-pseudomonal antibiotics against extensively drug-resistant Pseudomonas aeruginosa in a dynamic PK/PD model.
Montero MM, Domene-Ochoa S, Prim N, López-Causapé C, Echeverria-Esnal D, Sorlí L, Luque S, Padilla E, Grau S, Oliver A, Horcajada JP. Montero MM, et al. Among authors: prim n. Int J Antimicrob Agents. 2025 May;65(5):107477. doi: 10.1016/j.ijantimicag.2025.107477. Epub 2025 Feb 28. Int J Antimicrob Agents. 2025. PMID: 40024605 Free article.
79 results